Prospective study of the prognostic factors and clinical course in patients with Mycobacterium avium complex lung disease.
Not Applicable
Recruiting
- Conditions
- Mycobacterium avium complex (MAC) lung disease
- Registration Number
- JPRN-UMIN000019887
- Lead Sponsor
- Ohara Memorial Healthcare Foundation Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
thirteen months or more after diagnosis or treated already.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Poor prognostic factors in patients with MAC lung disease
- Secondary Outcome Measures
Name Time Method 1)procalcitonin (PCT) value in patients with MAC lung disease 2)PCT value according to the patient's severity with MAC lung disease 3)Usefulness of the serodiagnosis of MAC lung disease and the scoring system of chest images (NICE scoring system) for assess the severity of MAC lung disease, and usefulness of serial examinations. 4)The effect of treatment timing, regimen and duration to prognosis and clinical course